Scientific Poster Symposium Session 2 -- Clinical Pharmacy Forum

Wednesday, May 23, 2012: 7:00 PM-9:00 PM
39
Effect of Intrathecal Bupivacaine Lidocaine combination on Motor Block ,Analgesia Period and side effect profile
sarA.m Amin, bps, pharmacotherapy, certified1, manaL.h El-Hamamsy, Ass., Prof2 and azA.a Abd-El Alim, Ass., Prof2
1Ain Shams Universitty(cairo ,egypt), Cairo, Egypt
2Ain-Shams University, Egypt
46
Implementing a clinical pharmacy service in palliative care in a comprehensive cancer center in the Middle East
Sewar S. Alsalmany, MSc, BCPS and Lama H Nazer, Pharm.D , BCPS
King Hussein Cancer Center, Amman, Jordan
47E
Successes and challenges of Clinical Pharmacist Practitioners in North Carolina
Jonathan C. Hale, B.S. and Timothy J. Ives, PharmD., M.P.H., BCPS, FCCP, CPP
University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, NC
52
Descriptive Analysis of Quality Outcomes for Primary Care Clinical Pharmacy Service (PCCPS) Interventions
Rachel MF Heilmann, PharmD and Stephanie M. Campbell, PharmD
Kaiser Permanente Colorado, Denver, CO
53
Improving the performance measures of medical therapy in patients with acute myocardial infarction by pharmacist
Meng-Xian Huang, Bachelor, Ting-Ting Wu, Bachelor, Shin-Chia Tsai, Master, Yu-Mei Lin, Master and Wuan-Jin Leu, M.S.
Department of Pharmacy, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan
54
Does Meperidine Still Have a Place in Pain Control? The Evaluation of Meperidine Use in Adult Patients in a teaching hospital
Fang-Tzu Hsu, bachelor, degree, Ting-Ting Wu, bachelor, degree, Hsin-Chia Tsai, master, degree, Ting-Ting Huang, pharmacy student, Ching-Hsuan Tsao, pharmacy student, Meng-Hung Chen, pharmacy student and Yu-Mei Lin, master degree
Taipei Medical University- Shuang Ho Hospital, New Taipei City, Taiwan
55
Secure Messaging for Medication Reconciliation Tool (SMMRT): A “smart” approach to post-discharge medication reviews
Leonie Heyworth, MD1, Allison M. Paquin, PharmD1, Max Stewart, .1, Thomas Marcello, .1, Tracey Martin, RN, BSN1, Cliona Archambeault, MBA2 and Steven R. Simon, MD, MPH1
1VA Boston Healthcare System, Boston, MA
2New England Veterans Engineering Resource Center (VERC), Boston, MA
57
FLAG regimen with or without idarubicin in the treatment of refractory and relapsed acute myeloid leukemia: a single center experience
Rana A. Aljaber, PharmD, Salah Abbasi, M.D, Lina Marei, M.D, Mohammad Dowairi, M.D and Lama H. Nazer, pharmD, BCPS
King Hussien Cancer Center, Amman, Jordan